Continuum Advisory, LLC Sarepta Therapeutics, Inc. Transaction History
Continuum Advisory, LLC
- $680 Million
- Q2 2024
A detailed history of Continuum Advisory, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Continuum Advisory, LLC holds 10 shares of SRPT stock, worth $1,225. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10
Previous 17
41.18%
Holding current value
$1,225
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SRPT
# of Institutions
560Shares Held
85.5MCall Options Held
3.67MPut Options Held
1.75M-
Black Rock Inc. New York, NY10.3MShares$1.26 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.04MShares$1.11 Billion0.03% of portfolio
-
Capital International Investors Los Angeles, CA4.32MShares$529 Million0.14% of portfolio
-
State Street Corp Boston, MA4.14MShares$507 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X03.82MShares$467 Million0.33% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $10.7B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...